Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaffer R S Mok

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Annals of Surgical Oncology|November 5, 2025
Long-term Oncologic Outcomes Following Pathologic Complete Response for Esophageal CancerAndrew J Sinnamon, Samir H Saeed, Allan A Lima Pereira, et al.
G3 (Bethesda, Md.)|December 1, 2022
A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasmsMargaret A Park, Thinzar Zaw, Sean J Yoder, et al.
Cancer Medicine|April 11, 2026
Efficacy and Safety of Intensity-Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Real-World Cohort Study From a Single CenterLingxia Xin, Zhiyu Li, Yirui Zhai, et al.
Digestive Diseases and Sciences|November 5, 2024
Preventive Measures and Risk Factors for Post-ERCP Pancreatitis: A Systematic Review and Individual Patient Data Meta-AnalysisChristina J Sperna Weiland, Venkata S Akshintala, Anmol Singh, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Annals of Surgical Oncology|November 5, 2025
Long-term Oncologic Outcomes Following Pathologic Complete Response for Esophageal CancerAndrew J Sinnamon, Samir H Saeed, Allan A Lima Pereira, et al.
G3 (Bethesda, Md.)|December 1, 2022
A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasmsMargaret A Park, Thinzar Zaw, Sean J Yoder, et al.
Cancer Medicine|April 11, 2026
Efficacy and Safety of Intensity-Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Real-World Cohort Study From a Single CenterLingxia Xin, Zhiyu Li, Yirui Zhai, et al.
Digestive Diseases and Sciences|November 5, 2024
Preventive Measures and Risk Factors for Post-ERCP Pancreatitis: A Systematic Review and Individual Patient Data Meta-AnalysisChristina J Sperna Weiland, Venkata S Akshintala, Anmol Singh, et al.
Pageof 4